294 related articles for article (PubMed ID: 15665287)
1. Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat.
Paulsen JE; Løberg EM; Olstørn HB; Knutsen H; Steffensen IL; Alexander J
Cancer Res; 2005 Jan; 65(1):121-9. PubMed ID: 15665287
[TBL] [Abstract][Full Text] [Related]
2. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
[TBL] [Abstract][Full Text] [Related]
3. Identification of flat dysplastic aberrant crypt foci in the colon of azoxymethane-treated A/J mice.
Paulsen JE; Knutsen H; Ølstørn HB; Løberg EM; Alexander J
Int J Cancer; 2006 Feb; 118(3):540-6. PubMed ID: 16094649
[TBL] [Abstract][Full Text] [Related]
4. Prevalent location of flat dysplastic aberrant crypt foci near lymphoid follicles in the colon of azoxymethane-treated rats.
Paulsen JE; Steffensen IL; Olstørn HB; Alexander J
Anticancer Res; 2006; 26(3A):1803-7. PubMed ID: 16827110
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of PPARbeta/delta and cyclin D1 in flat dysplastic ACF and adenomas in Apc(Min/+) mice.
Knutsen HK; Olstørn HB; Paulsen JE; Husøy T; Goverud IL; Løberg EM; Kristiansen K; Alexander J
Anticancer Res; 2005; 25(6B):3781-9. PubMed ID: 16309164
[TBL] [Abstract][Full Text] [Related]
7. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
[TBL] [Abstract][Full Text] [Related]
8. Scanning electron microscopy of colonic lesions in 1,2-dimethylhydrazine-treated rats.
Paulsen JE; Namork E; Alexander J
Anticancer Res; 2005; 25(6B):3883-8. PubMed ID: 16309175
[TBL] [Abstract][Full Text] [Related]
9. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat.
Wargovich MJ; Chen CD; Jimenez A; Steele VE; Velasco M; Stephens LC; Price R; Gray K; Kelloff GJ
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):355-60. PubMed ID: 9162301
[TBL] [Abstract][Full Text] [Related]
10. Dark Aberrant Crypt Foci with activated Wnt pathway are related to tumorigenesis in the colon of AOM-treated rat.
Lu Q; Jiang B; Lin C; Shan T
J Exp Clin Cancer Res; 2008 Aug; 27(1):26. PubMed ID: 18681964
[TBL] [Abstract][Full Text] [Related]
11. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
[TBL] [Abstract][Full Text] [Related]
12. Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis.
Caderni G; Femia AP; Giannini A; Favuzza A; Luceri C; Salvadori M; Dolara P
Cancer Res; 2003 May; 63(10):2388-92. PubMed ID: 12750256
[TBL] [Abstract][Full Text] [Related]
13. Sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis.
Yamada Y; Yoshimi N; Hirose Y; Matsunaga K; Katayama M; Sakata K; Shimizu M; Kuno T; Mori H
Cancer Res; 2001 Mar; 61(5):1874-8. PubMed ID: 11280741
[TBL] [Abstract][Full Text] [Related]
14. Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis.
Papanikolaou A; Wang QS; Papanikolaou D; Whiteley HE; Rosenberg DW
Carcinogenesis; 2000 Aug; 21(8):1567-72. PubMed ID: 10910960
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor controls flat dysplastic aberrant crypt foci development and colon cancer progression in the rat azoxymethane model.
Dougherty U; Sehdev A; Cerda S; Mustafi R; Little N; Yuan W; Jagadeeswaran S; Chumsangsri A; Delgado J; Tretiakova M; Joseph L; Hart J; Cohen EE; Aluri L; Fichera A; Bissonnette M
Clin Cancer Res; 2008 Apr; 14(8):2253-62. PubMed ID: 18413814
[TBL] [Abstract][Full Text] [Related]
16. Correspondence between flat aberrant crypt foci and mucin-depleted foci in rodent colon carcinogenesis.
Femia AP; Paulsen JE; Dolara P; Alexander J; Caderni G
Anticancer Res; 2008; 28(6A):3771-5. PubMed ID: 19189663
[TBL] [Abstract][Full Text] [Related]
17. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells.
Raju J; Patlolla JM; Swamy MV; Rao CV
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1392-8. PubMed ID: 15298963
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of Centella asiatica on azoxymethane-induced aberrant crypt focus formation and carcinogenesis in the intestines of F344 rats.
Bunpo P; Kataoka K; Arimochi H; Nakayama H; Kuwahara T; Bando Y; Izumi K; Vinitketkumnuen U; Ohnishi Y
Food Chem Toxicol; 2004 Dec; 42(12):1987-97. PubMed ID: 15500935
[TBL] [Abstract][Full Text] [Related]
19. Effects of repeated boluses of sucrose on proliferation and on AOM-induced aberrant crypt foci in rat colon.
Luceri C; Caderni G; Lancioni L; Aiolli S; Dolara P; Mastrandrea V; Scardazza F; Morozzi G
Nutr Cancer; 1996; 25(2):187-96. PubMed ID: 8710688
[TBL] [Abstract][Full Text] [Related]
20. Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Ochiai M; Ushigome M; Fujiwara K; Ubagai T; Kawamori T; Sugimura T; Nagao M; Nakagama H
Am J Pathol; 2003 Oct; 163(4):1607-14. PubMed ID: 14507667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
